Recent Diagnostic and Therapeutic Advances Across the Global Biotech Landscape

USD 250.00

* Required Fields

USD 250.00


Be the first to review this product

This edition of the Genetic Technology TOE depicts new life sciences trends across diagnostics and therapeutics. Different diagnostic approaches including liquid biopsy tests for autism and related disorders are illustrated along with a number of therapeutic innovations for neurodegenerative diseases. The recent advances in personalized medicine initiatives in oncology and the consequent progress across the immuno-oncology pipeline are also included. The corresponding clinical trials scenario is also depicted.The Genetic Technology TechVision Opportunity Engine (TOE) presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic technology through

Table of Contents

Recent Diagnostic and Therapeutic Advances Across the Global Biotech LandscapeDiagnostic and Therapeutic Advances in BiotechLiquid Biopsy Test for AutismNovel Therapeutics for Neurodegenerative DiseasesAdvancing Personalized Medicine Initiatives in OncologyAdvances in Immuno-oncology PipelineClinical Trial Analysis and Industry InteractionsClinical Trial AnalysisKey Contacts

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.